GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Raymed Labs Ltd (BOM:531207) » Definitions » 10-Year ROIIC %

Raymed Labs (BOM:531207) 10-Year ROIIC % : 4.49% (As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Raymed Labs 10-Year ROIIC %?

10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year. Raymed Labs's 10-Year ROIIC % for the quarter that ended in Mar. 2024 was 4.49%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Raymed Labs's 10-Year ROIIC % or its related term are showing as below:

BOM:531207's 10-Year ROIIC % is ranked better than
69.6% of 1260 companies
in the Biotechnology industry
Industry Median: -32.185 vs BOM:531207: 4.49

Raymed Labs 10-Year ROIIC % Historical Data

The historical data trend for Raymed Labs's 10-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Raymed Labs 10-Year ROIIC % Chart

Raymed Labs Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
10-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -5.36 76.43 3.02 2.80 4.49

Raymed Labs Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
10-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 4.49 - - -

Competitive Comparison of Raymed Labs's 10-Year ROIIC %

For the Biotechnology subindustry, Raymed Labs's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Raymed Labs's 10-Year ROIIC % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Raymed Labs's 10-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Raymed Labs's 10-Year ROIIC % falls into.



Raymed Labs 10-Year ROIIC % Calculation

Raymed Labs's 10-Year ROIIC % for the quarter that ended in Mar. 2024 is calculated as:

10-Year ROIIC %=10-Year Incremental Net Operating Profit After Taxes (NOPAT)**/10-Year Incremental Invested Capital**
=( -1.016 (Mar. 2024) - -0.127 (Mar. 2014) )/( 2.341 (Mar. 2024) - 22.132 (Mar. 2014) )
=-0.889/-19.791
=4.49%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Raymed Labs  (BOM:531207) 10-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Raymed Labs 10-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Raymed Labs's 10-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Raymed Labs Business Description

Traded in Other Exchanges
N/A
Address
C-273, Sector-63, Noida, UP, IND, 201301
Raymed Labs Ltd is an Indian company engaged in the business of pharmaceutical sector. The company is involved in manufacturing as well as trading medicines and chemicals. Business operations activities include; manufacturers and producers, buyers and sellers, trading, stores and stockists, suppliers and distributors, wholesale and retail dealers in pharmaceuticals, medicals, chemicals, industrial and other preparations and articles, compounds, drugs, veterinary and human medicines, and others.

Raymed Labs Headlines

No Headlines